CD177 and cancer: IL-13RA2 is a cell surface receptor that is not significantly expressed in normal brain tissue; however, it is overexpressed in most cancer cells and is currently important in the treatment of brain tumors (Debinski et al., 1999; Kawakami et al., 2004; Brown et al., 2012; Brown et al., 2016).